Neeha Zaidi

13PUBLICATIONS
93CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Sequence analysisHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 16, 2026
First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts.

|Jun 23, 2026
Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trial.

|Apr 15, 2026
Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.

|Apr 01, 2026
The Seven Ps of Cancer Interception.

Dimitrios N Sidiropoulos, Neeha Zaidi, Mark Yarchoan

|Feb 10, 2026
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.

Amanda L Huff, S Daniel Haldar, Alexander A Gergis

|Nov 25, 2025
A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trial.

Marina Baretti, Allison M Kirk, Brian H Ladle

Pageof 3

Frequent Collaborators

12 joint publications

Elizabeth M Jaffee

8 joint publications

Mark Yarchoan

6 joint publications

Luciane T Kagohara

5 joint publications

Christopher Thoburn